PubMedCrossRef 49 Rawson ES, Venezia AC: Use of creatine in the

PubMedCrossRef 49. Rawson ES, CFTRinh-172 chemical structure Venezia AC: Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids 2011, 40:1349–1362.PubMedCrossRef 50. Beal MF: Neuroprotective effects of creatine. Amino Acids 2011, 40:1305–1313.PubMedCrossRef 51. Braissant O, Henry H, Béard E, Uldry J: Creatine deficiency syndromes and the importance

of creatine synthesis in the brain. Amino Acids 2011, 40:1315–1324.PubMedCrossRef 52. Metzl JD, Small E, Levine SR, Gershel JC: Creatine use among young athletes. Pediatrics 2001, 108:421–425.PubMedCrossRef 53. Evans MW, Ndetan H, Perko M, Williams R, Walker C: Dietary supplement use by children and adolescents in the United States to Enhance check details sport performance: results of the national health interview survey. J Prim Prev 2012, 33:3–12.PubMedCrossRef 54. Unnithan VB, Veehof SH, Vella CA, Kern M: Is there a physiologic basis for creatine use in children and adolescents? J Strength Cond Res 2001, 15:524–528.PubMed 55. Willoughby DS, Rosene J: Effects of oral creatine and resistance training

on myosin heavy chain expression. Med Sci Sports Exerc 2001, 33:1674–1681.PubMedCrossRef 56. Sale C, Harris RC, Florance J, Kumps A, Sanvura R, Poortmans JR: Urinary creatine and methylamine excretion following 4 x 5 g x day(-1) or 20 x 1 g x day(-1) of creatine monohydrate for 5 days. J Sports Sci 2009, 27:759–766.PubMedCrossRef 57. Syrotuik DG, Bell GJ: Acute creatine monohydrate supplementation: a descriptive physiological profile of responders vs. nonresponders. J Strength Cond Res 2004, 18:610–617.PubMed 58. Greenhaff PL, Bodin K, Soderlund K, Hultman E: Effect of CYT387 ic50 oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 1994, 266:E725-E730.PubMed 59. Ganguly

S, Jayappa S, Dash AK: Evaluation of the stability of creatine in solution prepared from effervescent creatine formulations. AAPS PharmSciTech 2003, 4:E25.PubMedCrossRef 60. Jäger R, Harris RC, Purpura M, Francaux M: Comparison of new forms 4��8C of creatine in raising plasma creatine levels. J Int Soc Sports Nutr 2007, 4:17.PubMedCrossRef 61. Jäger R, Metzger J, Lautmann K, Shushakov V, Purpura M, Geiss K, Maassen N: The effects of creatine pyruvate and creatine citrate on performance during high intensity exercise. J Int Soc Sports Nutr 2008, 5:4.PubMedCrossRef 62. Jäger R, Purpura M, Shao A, Inoue T, Kreider RB: Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids 2011, 40:1369–83.PubMedCrossRef 63. Gufford BT, Sriraghavan K, Miller N, Miller D, Gu X, Vennerstrom J, Robinson D: Physicochemical characterization of creatine N-methylguanidinium salts. Journal of Dietary Supplements 2010, 7:240–252.PubMedCrossRef 64. Persky AM, Brazeau GA, Hochhaus G: Pharmacokinetics of the dietary supplement creatine. Clin Pharmacokinet 2003, 42:557–574.PubMedCrossRef 65.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>